3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
440
Rectal Neoplasms
209
Colonic Neoplasms
201
Pancreatic Neoplasms
131
Stomach Neoplasms
116
Neoplasm Metastasis
97
Neoplasms
63
Esophageal Neoplasms
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
51
Lymphoma
49
Leukemia
41
Carcinoma, Hepatocellular
40
Adenocarcinoma Of Esophagus
37
Burkitt Lymphoma
33
Adenocarcinoma
29
Cholangiocarcinoma
26
Biliary Tract Neoplasms
22
Carcinoma, Non-Small-Cell Lung
21
Gastrointestinal Neoplasms
20
Lymphoma, Non-Hodgkin
19
Gallbladder Neoplasms
19
Esophageal Squamous Cell Carcinoma
15
Osteosarcoma
14
Bile Duct Neoplasms
14
Unspecified Adult Solid Tumor, Protocol Specific
13
Lymphoma, Large B-Cell, Diffuse
13
Liver Neoplasms
13
Leukemia, Biphenotypic, Acute
13
Ovarian Neoplasms
12
Leukemia, Myeloid, Acute
12
Interventions
Cisplatin
178
Paclitaxel
79
Radiotherapy
76
Carboplatin
70
Brachytherapy
69
pembrolizumab
63
Bevacizumab
40
Gemcitabine
28
Radiation
27
Topotecan
26
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
25
Nivolumab
22
Colposcopy
22
human papillomavirus vaccine, L1 type 16, 18
21
Magnetic Resonance Spectroscopy
21
Drug Therapy
20
atezolizumab
19
Platinum
19
Papillomavirus Vaccines
18
Radiotherapy, Intensity-Modulated
17
Docetaxel
17
Taxes
16
Cyclophosphamide
16
Biopsy
16
Early Intervention, Educational
15
1,2-diaminocyclohexaneplatinum II citrate
15
Methods
14
Blood Specimen Collection
14
fludarabine
13
Injections
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Uterine Cervical Neoplasms
×
Leucovorin
×
Clear all
NCT05891171
2026-06-05
ARC-25
Arcus Biosciences, Inc.
Phase 1
Active not recruiting
40 enrolled